Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of “Hold” by Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given an average rating of “Hold” by the nine analysts that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have given a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $21.56.

Several research analysts recently issued reports on the stock. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. Finally, UBS Group assumed coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock.

Insider Buying and Selling

In other news, CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at $2,640,330.88. This trade represents a 5.24 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Steven Wolin sold 19,580 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the transaction, the chief operating officer now directly owns 102,598 shares of the company’s stock, valued at $1,854,971.84. This represents a 16.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp lifted its holdings in shares of Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock worth $108,867,000 after buying an additional 291,335 shares in the last quarter. Versor Investments LP bought a new position in Oscar Health in the third quarter valued at about $787,000. Janney Montgomery Scott LLC bought a new stake in shares of Oscar Health during the third quarter worth about $988,000. Nordea Investment Management AB bought a new stake in shares of Oscar Health during the fourth quarter worth about $1,056,000. Finally, Algert Global LLC lifted its stake in shares of Oscar Health by 63.3% in the third quarter. Algert Global LLC now owns 369,685 shares of the company’s stock worth $7,841,000 after acquiring an additional 143,346 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Trading Up 6.5 %

OSCR opened at $15.92 on Friday. The firm’s 50-day simple moving average is $15.03 and its 200-day simple moving average is $16.83. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a twelve month low of $10.45 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm’s quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.29) EPS. As a group, sell-side analysts forecast that Oscar Health will post -0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.